1. Home
  2. EXP vs RGEN Comparison

EXP vs RGEN Comparison

Compare EXP & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXP
  • RGEN
  • Stock Information
  • Founded
  • EXP 1963
  • RGEN 1981
  • Country
  • EXP United States
  • RGEN United States
  • Employees
  • EXP N/A
  • RGEN N/A
  • Industry
  • EXP Building Materials
  • RGEN Medical/Dental Instruments
  • Sector
  • EXP Industrials
  • RGEN Health Care
  • Exchange
  • EXP Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • EXP 8.0B
  • RGEN 7.6B
  • IPO Year
  • EXP 1994
  • RGEN N/A
  • Fundamental
  • Price
  • EXP $256.62
  • RGEN $160.51
  • Analyst Decision
  • EXP Buy
  • RGEN Buy
  • Analyst Count
  • EXP 9
  • RGEN 12
  • Target Price
  • EXP $301.44
  • RGEN $187.44
  • AVG Volume (30 Days)
  • EXP 283.9K
  • RGEN 521.6K
  • Earning Date
  • EXP 01-27-2025
  • RGEN 02-19-2025
  • Dividend Yield
  • EXP 0.39%
  • RGEN N/A
  • EPS Growth
  • EXP 3.40
  • RGEN N/A
  • EPS
  • EXP 14.09
  • RGEN N/A
  • Revenue
  • EXP $2,267,848,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • EXP $3.13
  • RGEN $2.28
  • Revenue Next Year
  • EXP $5.79
  • RGEN $9.88
  • P/E Ratio
  • EXP $18.22
  • RGEN N/A
  • Revenue Growth
  • EXP 2.83
  • RGEN N/A
  • 52 Week Low
  • EXP $200.08
  • RGEN $113.50
  • 52 Week High
  • EXP $321.93
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • EXP 49.85
  • RGEN 62.61
  • Support Level
  • EXP $233.19
  • RGEN $150.23
  • Resistance Level
  • EXP $249.62
  • RGEN $160.64
  • Average True Range (ATR)
  • EXP 5.26
  • RGEN 6.76
  • MACD
  • EXP 3.10
  • RGEN 1.14
  • Stochastic Oscillator
  • EXP 90.45
  • RGEN 80.27

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: